Skip to content

CEDEK MEDICAL

Active
Private limited companyfounded 1991active for 35 yearsRue Charles-Magnette 6, 4000 Liège, BelgiumKBO/BCE: BE 0443.485.087
Summary

CEDEK MEDICAL has been active since 1991 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €941,228 and a net result of €276,198. Equity remains stable across the filed financial years (±1.5% per year). Its solvency ranks better than 84% of 270 sector peers (NACE 32, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Activity
Manufacture of medical and dental instruments and supplies
NACE 32500Retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses NACE 47741
1 site
Size
€1.2mtotal assets 2025
Staff
4.8 FTE
Equity
€941,228
Profit
€276,198
Financial health
98 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Structure
Parent
TAHAA HOLDING · 99.73%
Accounts filed 27 days late1 of 3 deeds read
Why 98raises riskLatest accounts 27 days late; 1 of the last 3 latelowers riskLiquidity: current ratio 4.09, cash €287,192Founded in 1991Equity €941,228 (78.1% of total assets)Show the evidence

Checked score

Score 2025
98 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 83% of its sector peers (NACE 32, micro)
Financial strength · tick = 2024
Strong
Solvency 100+17
equity 78.1% of total assets
Liquidity 72-8
short-term debt 21.9% · cash 23.8%
Profitability 97-3
return on assets 22.9%
Bankruptcy probability, 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.3% (1,139 companies, NACE 32, micro)
Last 24 months 11-2024: < 0.1% 12-2024: < 0.1%● unchanged vs 11-2024 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: 0.1%▲ +0.1 percentage points vs 07-2025 09-2025: 0.1%● unchanged vs 08-2025highest value 10-2025: < 0.1%▼ -0.1 percentage points vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: 0.1%▲ +0.1 percentage points vs 07-2026 09-2026: < 0.1%▼ -0.1 percentage points vs 08-2026lowest value 10-2026: < 0.1%● unchanged vs 09-2026lowest value
Credit of up to €90,000 on 30-day terms is acceptable
Liquidity ample (current ratio 4.09, compared with 2.25 in 2024, above the usual 1.5; short-term debt: 21.9% and cash: 23.8% of total assets), and 21.9% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 32, micro): better than 90% on solvency, 72% on liquidity, 85% on profitability and 84% on growth.

The bankruptcy probability was computed on 16-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.
lowers riskraises riskneutral
lowers risk · Liquidity: current ratio 4.09, cash €287,192
NBB · annual accounts
lowers risk · Founded in 1991
Companies that have existed this long fail less often; how much that weighs depends on the rest of its profile.
KBO
lowers risk · Equity €941,228 (78.1% of total assets)
NBB · annual accounts
raises risk · Latest accounts 27 days late; 1 of the last 3 late
NBB · filings
lowers risk · Growing equity
Reported equity is higher than in 2023 and did not fall compared with 2024. These amounts do not establish the cause of the change.
NBB · annual accounts 2025
Equity per financial year
1819202122232425
2018 to 2025 · latest year €941,228
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 27-08-2026, 27 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 10 filings
Deviation from the deadline
2025
27 days late
2024
40 days late
2023
117 days early
2022
68 days early
2021
53 days early
2020
25 days early
2019
67 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 18 days before the deadline; the sector median (NACE 32) for financial year 2024 is 2 days before the deadline, and 39% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 8 June (4 of the last 5 filed years within 80 days of that day).
Companies Code · seven months
Where today falls in the filing period
17-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · abbreviated…
  2. Annual accounts filedfinancial year 2024 · full…
  3. Highest result from 2018 to 2025net €335,634 ▲161%

Key points

  • Positive: Among the best 13% on net resultsector median €27,934 · 270 companies €276,198 View
  • Positive: 8 profitable years in a rowprofit 2025: €276,198 8 years View
  • Controlled by TAHAA HOLDING 99.73% View
  • Positive: Equity rose in 2025from €665,030 to €941,228 ▲ 41.5% View

By topic

Financials

Financial year
2025
Total assets
€1.2m
Profit
€276,198
Solvency
78.1%
Total assets▲ 4.9%
Net result
20182025
Go to Financials

Timeline

Events
39
Since
1992
Next accounts
by 31-07-2027
  1. 31-12-2024Equity above €500,000
  2. 30-07-2024Resignation: Sebastien Dekeyser (director)
  3. 05-04-2024Annual accounts filed
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
Manufacture of medical and dental instruments and suppliesNACE 32500
Founded
07-03-1991
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.